Activin and Inhibin

GRK5-IN-2 (compound 707), a pyridine-based bicyclic compound, is a potent G-protein-coupled receptor kinase 5 (GRK5) inhibitor. GRK5-IN-2 regulates the expression and/or release of insulin and is useful for the metabolic disease

GRK5-IN-2 (compound 707), a pyridine-based bicyclic compound, is a potent G-protein-coupled receptor kinase 5 (GRK5) inhibitor. GRK5-IN-2 regulates the expression and/or release of insulin and is useful for the metabolic disease

GRK5-IN-2 (compound 707), a pyridine-based bicyclic compound, is a potent G-protein-coupled receptor kinase 5 (GRK5) inhibitor. GRK5-IN-2 regulates the expression and/or release of insulin and is useful for the metabolic disease researchIC50&amp:

GRK6-IN-1 (compound 18) is a potent inhibitor of G protein-coupled receptor kinase 6 ( GRK6 ) with an IC 50 of 120 nM. GRK6 is a critical kinase required for the survival of multiple myeloma (MM) cells. GRK6-IN-1 has the potential for the research

GRK6-IN-1 (compound 18) is a potent inhibitor of G protein-coupled receptor kinase 6 ( GRK6 ) with an IC 50 of 120 nM. GRK6 is a critical kinase required for the survival of multiple myeloma (MM) cells. GRK6-IN-1 has the potential for the research

GRK6-IN-1 (compound 18) is a potent inhibitor of G protein-coupled receptor kinase 6 ( GRK6 ) with an IC 50 of 120 nM. GRK6 is a critical kinase required for the survival of multiple myeloma (MM) cells. GRK6-IN-1 has the potential for the research

GRK6-IN-1 (compound 18) is a potent inhibitor of G protein-coupled receptor kinase 6 ( GRK6 ) with an IC 50 of 120 nM. GRK6 is a critical kinase required for the survival of multiple myeloma (MM) cells. GRK6-IN-1 has the potential for the research

GRK6-IN-1 (compound 18) is a potent inhibitor of G protein-coupled receptor kinase 6 ( GRK6 ) with an IC 50 of 120 nM. GRK6 is a critical kinase required for the survival of multiple myeloma (MM) cells. GRK6-IN-1 has the potential for the research

GRK6-IN-2 (compound 10a) is a potent inhibitor of G protein-coupled receptor kinase 6 ( GRK6 ) with an IC 50 of 120 nM. GRK6 is a critical kinase required for the survival of multiple myeloma (MM) cells. GRK6-IN-2 has the potential for the research

GRK6-IN-2 (compound 10a) is a potent inhibitor of G protein-coupled receptor kinase 6 ( GRK6 ) with an IC 50 of 120 nM. GRK6 is a critical kinase required for the survival of multiple myeloma (MM) cells. GRK6-IN-2 has the potential for the research

GRK6-IN-2 (compound 10a) is a potent inhibitor of G protein-coupled receptor kinase 6 ( GRK6 ) with an IC 50 of 120 nM. GRK6 is a critical kinase required for the survival of multiple myeloma (MM) cells. GRK6-IN-2 has the potential for the research

GRK6-IN-2 (compound 10a) is a potent inhibitor of G protein-coupled receptor kinase 6 ( GRK6 ) with an IC 50 of 120 nM. GRK6 is a critical kinase required for the survival of multiple myeloma (MM) cells. GRK6-IN-2 has the potential for the research